A fluorogenic ROS-triggered hydrogen sulfide donor for alleviating cerebral ischemia-reperfusion injury
2024

A New Hydrogen Sulfide Donor to Help Stroke Recovery

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lu Huangjie, Zeng Huiying, Wei Wenlong, Chen Yuying, Zhou Ziqiang, Ning Xuyang, Hu Ping

Primary Institution: Jinan University

Hypothesis

Can a novel hydrogen sulfide donor improve outcomes in cerebral ischemia-reperfusion injury?

Conclusion

The hydrogen sulfide donor HSDF-NH2 shows promise in treating ischemic diseases by reducing brain injury and improving recovery.

Supporting Evidence

  • HSDF-NH2 effectively scavenges reactive oxygen species while generating hydrogen sulfide.
  • Treatment with HSDF-NH2 significantly reduced infarct size in a rat stroke model.
  • HSDF-NH2 improved neurological function scores in treated rats compared to control groups.

Takeaway

Scientists created a special compound that helps protect the brain during a stroke, making it heal better and faster.

Methodology

The study used a rat model of stroke to test the effects of HSDF-NH2 on brain injury and recovery.

Limitations

The study primarily focused on a rat model, which may not fully replicate human responses.

Participant Demographics

Adult male Sprague-Dawley rats, aged 10-12 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/thno.100930

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication